BioMarin Bumped Up: Fool by Numbers

• Email
• Share
• Print

On Nov. 1, BioMarin Pharmaceutical (Nasdaq: BMRN) released third-quarter earnings for the period ended Sept. 30.

• Revenues beat the estimates by 11.2%, while EPS topped the consensus estimate with a loss of $0.08.
  
  
• Revenue increases were mainly due to stronger product sales, particularly in Aldurazyme and Naglazyme.
  
  
• Restrained spending and top-line growth let to a significant movement toward profitability.
  
  
• Get our full Foolish Take on BioMarin's latest quarter.

(Figures in thousands, except per-share data)

Income Statement Highlights

	Avg. Est.	Q3 2006	Q3 2005	Change
Sales	$19,716	$24,927	$7,579	228.9%
Net Profit*	--	($7,036)	($15,476)	N/A
EPS	($0.12)	($0.08)	($0.21)	N/A
Diluted Shares	--	86,269	71,996	19.8%

Get back to basics with a look at the income statement.

Margin Checkup

	Q3 2006	Q3 2005	Change*
Gross Margin	89.52%	97.84%	(8.32)
Operating Margin	(16.51%)	(173.82%)	157.31
Net Margin	(28.23%)	(204.20%)	175.97

*Expressed in percentage points.

Margins are the earnings engine. See how they work.

Balance Sheet Highlights

Assets	Q3 2006	Q3 2005	Change
Cash + ST Invest.	$293.9	$65.9	346%
Accounts Rec.	$13.0	$5.3	145.3%
Inventory	$25.8	$7.7	235.1%

Liabilities	Q3 2006	Q3 2005	Change
Accounts Payable*	$29.2	$22.9	27.5%
Long-Term Debt	$293.1	$214.4	36.7%

*Includes accrued liabilities.

Learn the ways of the balance sheet.

Cash Flow Highlights

A statement of cash flows was not provided.

Find out why Fools always follow the money.

Related Companies:

• Medarex (Nasdaq: MEDX)
• Crucell NV (Nasdaq: CRXL)
• Regeneron Pharmaceuticals (Nasdaq: REGN)
• ZymoGenetics (Nasdaq: ZGEN)

Related Foolishness:

• BioMarin's in Good Health
• All-Star Stocks: Grand Slam Biotechs

Get the latest updates from the fast-paced world of biotech, and other spawning grounds for amazing growth stocks, with a free 30-day trial to Motley Fool Rule Breakers.

Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.